Akari Therapeutics PLC (NASDAQ:AKTX)

1.67
BATS BZX Real-Time Price
As of 10:29am ET
 -0.01 / -0.60%
Today’s Change
0.87
Today|||52-Week Range
2.79
-4.57%
Year-to-Date
Akari Therapeutics reports Q2 results
Sep 01 / Seeking Alpha - Paid Partner Content
AMRN, DVAX among premarket gainers
Aug 31 / Seeking Alpha - Paid Partner Content
Akari Therapeutics +7% on developmental plans of nomacopan for COVID-19
Aug 31 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close1.68
Today’s open1.67
Day’s range1.67 - 1.67
Volume1,230
Average volume (3 months)331,835
Market cap$57.2M
Data as of 10:29am ET, 09/29/2020

Growth & Valuation

Earnings growth (last year)+12.12%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc-0.04-4.15%
CWBRCohBar Inc-0.00-0.48%
PTIProteostasis Therape...+0.01+0.92%
ARMPArmata Pharmaceutica...+0.12+4.02%
Data as of 11:13am ET, 09/29/2020

Financials

Next reporting dateNovember 12, 2020
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$17.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
London, London & South East

Forecasts